1596341-51-3

Basic information

• Product Name: methyl 2-[3-(4-chloro-1H-pyrazol-1-yl)-2-(3,4-dihydro-2H-1-benzopyran-6-yl)-6-(trifluoromethyl)phenyl]-2-oxoacetate
• Synonyms: methyl 2-[3-(4-chloro-1H-pyrazol-1-yl)-2-(3,4-dihydro-2H-1-benzopyran-6-yl)-6-(trifluoromethyl)phenyl]-2-oxoacetate
• CAS NO: 1596341-51-3
• Molecular Weight: 464.828
• Mol File: 1596341-51-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: methyl 2-[3-(4-chloro-1H-pyrazol-1-yl)-2-(3,4-dihydro-2H-1-benzopyran-6-yl)-6-(trifluoromethyl)phenyl]-2-oxoacetate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-[3-(4-chloro-1H-pyrazol-1-yl)-2-(3,4-dihydro-2H-1-benzopyran-6-yl)-6-(trifluoromethyl)phenyl]-2-oxoacetate(1596341-51-3)
• EPA Substance Registry System: methyl 2-[3-(4-chloro-1H-pyrazol-1-yl)-2-(3,4-dihydro-2H-1-benzopyran-6-yl)-6-(trifluoromethyl)phenyl]-2-oxoacetate(1596341-51-3)

Safety Data

• Hazardous Substances Data: 1596341-51-3(Hazardous Substances Data)

Upstream product

• 1403382-23-9 methyl 2-[2-(3,4-dihydro-2H-1-benzopyran-6-yl)-3-fluoro-6-(trifluoromethyl)phenyl]-2-oxoacetate 
• 77-78-1 dimethyl sulfate 
• 141483-15-0 2-fluoro-5-trifluoromethylphenol 
• 1596341-32-0 2-[2-(3,4-dihydro-2H-1-benzopyran-6-yl)-3-fluoro-6-(trifluoromethyl)phenyl]-2-oxoacetic acid 
• 1403382-21-7 ethyl 2-[3-fluoro-2-hydroxy-6-(trifluoromethyl)phenyl]-2-oxoacetate 
• 1403382-20-6 ethyl 2-[3-fluoro-2-(methoxymethoxy)-6-(trifluoromethyl)phenyl]-2-oxoacetate 
• 866615-03-4 1-fluoro-2-(methoxymethoxy)-4-(trifluoro methyl)benzene 
• 15878-00-9 4-chloro-1H-pyrazole 
• 1403382-22-8 ethyl 2-{3-fluoro-2-[(trifluoromethane) sulfonyloxy]-6-(trifluoromethyl)phenyl)-2-oxoacetate 

Downstream Products

• 1596341-52-4 methyl 2-[3-(4-chloro-1H-pyrazol-1-yl)-2-(3,4-dihydro-2H-1-benzopyran-6-yl)-6-(trifluoromethyl)phenyl]-2-hydroxyacetate 

Relevant articles and documents

INHIBITORS OF VIRAL REPLICATION, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES

Inhibitors of viral replication of formula (I), their process of preparation and their therapeutical uses. The present invention relates to compounds, their use in the treatment or the prevention of viral disorders, including HIV.